MJoTAtalks

Dr Susanna's guide to

www.MJoTA.org
click here

www.MJoTAtalks.org click here

www.drsusanna.org click here



Dr Susanna loves the countries and the peoples of Africa
 
Bookmark and Share
Diabetes news from the American Diabetes Association

Latest Top (20) News
Diabetes News
Diabetes news from the National Institutes of Health Diabetes Educators.

Latest Top (10) News
Clinical trials testing therapies for diabetes

Latest Top (10) News


Adapting Critical Time Intervention to Support Inpatient Medical Care Transition
Conditions:   Schizophrenia;   Ambulatory Care Sensitive Conditions
Intervention:   Other: Critical time intervention
Sponsors:   New York State Psychiatric Institute;   Healthfirst;   Montefiore Medical Center;   Bronx-Lebanon Hospital Center Health Care System
Not yet recruiting

Fri, 17 Aug 2018 12:00:00 EDT


Cell Therapy for Peripheral Arterial Disease and Diabetes
Conditions:   Peripheral Arterial Disease;   Diabetes Mellitus
Intervention:   Procedure: celular therapy
Sponsors:   Hospital Regional de Alta Especialidad del Bajio;   Instituto Mexicano del Seguro Social
Active, not recruiting

Fri, 17 Aug 2018 12:00:00 EDT


Circulating microRNAs and Adverse Cardiovascular Outcomes in Patients With Coronary Artery Disease
Condition:   the Feasibility of Detecting and Quantifying Circulating miRNA Expression in Human Subjects
Intervention:  
Sponsor:   National Taiwan University Hospital
Recruiting

Fri, 17 Aug 2018 12:00:00 EDT


Comparative Evaluation of the Evolution of Arterial and Microcirculatory Endothelial Function in Obese Patients With Type-2 Diabetes Versus Non-diabetic Obese Patients After a First Bariatric Surgery
Conditions:   Bariatric Surgery;   Obese;   Type2 Diabetes
Interventions:   Biological: Vasculary biological assessment;   Biological: Analysis of vasomotor endothelial function;   Biological: Analysis of arterial compliance;   Biological: Exploration of microcirculation;   Biological: Venous Doppler Ultrasound;   Biological: Arterial pressure measurement;   Biological: Intima-Media Thickness measurement;   Biological: Exploration of neuropathy;   Behavioral: level of physical activity
Sponsor:   Centre Hospitalier Universitaire de Nīmes
Not yet recruiting

Fri, 17 Aug 2018 12:00:00 EDT


Diabetic Retinopathy and Subclinical Signs of Disease Transition
Condition:   Diabetic Retinopathy
Intervention:   Diagnostic Test: Optical Coherence Tomography Angiography
Sponsor:   University of British Columbia
Recruiting

Fri, 17 Aug 2018 12:00:00 EDT


Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?
Condition:   Bullous Pemphigoid
Intervention:   Drug: data report
Sponsor:   Assistance Publique Hopitaux De Marseille
Recruiting

Fri, 17 Aug 2018 12:00:00 EDT


Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)
Condition:   Cervical Cancer
Interventions:   Biological: Pembrolizumab;   Drug: Paclitaxel;   Drug: Cisplatin;   Drug: Carboplatin;   Biological: Bevacizumab;   Drug: Placebo to pembrolizumab
Sponsor:   Merck Sharp & Dohme Corp.
Not yet recruiting

Fri, 17 Aug 2018 12:00:00 EDT


Evaluation of Safety and Diabetes Status Upon Oral Treatment With GABA in Patients With Longstanding Type-1 Diabetes
Condition:   Type 1 Diabetes Mellitus
Intervention:   Drug: Gamma-Aminobutyric Acid (GABA)
Sponsors:   Per-Ola Carlsson;   Diamyd Medical AB
Not yet recruiting

Fri, 17 Aug 2018 12:00:00 EDT


Focus Group Study of Lifelong Food and Nutrition Assistance (LIFANA) in Stroke Patients and Caregivers
Conditions:   Stroke;   Relatives;   Diet Modification
Intervention:   Other: Qualitative interview study
Sponsors:   Cereneo AG;   cereneo Institute for Interdsciplinary Research (cefir)
Enrolling by invitation

Fri, 17 Aug 2018 12:00:00 EDT


Laboratory, Cellular and Molecular Determinants of Clinical Success in Diabetic Patients With Critical Limb Ischemia
Conditions:   Diabetes Mellitus;   Critical Limb Ischemia;   Critical Lower Limb Ischemia;   Diabetic Foot
Intervention:   Other: data and specimen collection
Sponsor:   Maria Cecilia Hospital
Recruiting

Fri, 17 Aug 2018 12:00:00 EDT
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder
FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder

Fri, 17 Aug 2018 09:46:00 -0400


FDA approves first generic version of EpiPen
FDA approves the first generic version of EpiPen and EpiPen Jr for the emergency treatment of allergic reactions in adults and pediatric patients who weigh more than 33 pounds.

Thu, 16 Aug 2018 12:55:00 -0400


Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing the science and regulation of live microbiome-based products used to prevent, treat, or cure diseases in humans
FDA announces workshop on advancing the science and regulation of live microbiome-based products used to prevent, treat, or cure diseases in humans.

Thu, 16 Aug 2018 12:34:00 -0400


Statement from FDA Commissioner Scott Gottlieb, M.D., on significant public health value and cost savings resulting from the agency’s youth smoking prevention campaign
A cost-effectiveness analysis of the FDA’s “The Real Cost” youth smoking prevention campaign shows it has resulted in savings of more than $31 billion for youth, their families and society at large.

Thu, 16 Aug 2018 10:06:00 -0400


Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new resource guide to support responsible opioid prescribing for pain management in animals
Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new resource guide in support of responsible opioid prescribing for safe, effective pain management in animals

Wed, 15 Aug 2018 12:14:00 -0400


FDA approves new treatment for a rare genetic disorder, Fabry disease
FDA approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.

Fri, 10 Aug 2018 16:37:00 -0400


FDA approves new vaginal ring for one year of birth control
FDA approved Annovera (segesterone acetate and ethinyl estradiol vaginal system), a combined hormonal contraceptive for women of reproductive age used to prevent pregnancy and is the first vaginal ring contraceptive that can be used for an entire year.

Fri, 10 Aug 2018 13:54:00 -0400


FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease
FDA approves new drug for treatment of polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR). This is the first FDA-approved treatment for this rare, debilitating and often fatal genetic disease and the first FDA approval of a new class of drugs called small interfering ribonucleic acid (siRNA) treatment.

Fri, 10 Aug 2018 12:51:00 -0400


FDA allows marketing of first direct-to-consumer app for contraceptive use to prevent pregnancy
The app uses basal body temperature readings to predict when a woman is most fertile to help her avoid conceiving on those days if using as a form of contraception

Fri, 10 Aug 2018 12:02:00 -0400


FDA alerts healthcare providers, women about risks associated with improper use of rupture of membranes tests
FDA alerts healthcare providers, women about risks associated with improper use of rupture of membranes tests

Wed, 08 Aug 2018 13:33:00 -0400